545 Results

People

  1. Motzer
    Motzer
  2. Bosl
    Bosl
  3. Sheinfeld
    Sheinfeld
  4. Yahalom
    Yahalom
  5. Bajorin
    Bajorin
  6. Straus
    Straus
  7. Feldman
    Feldman
  8. Kelsen
    Kelsen
  9. Moskowitz
    Moskowitz
  10. Herr
    Herr

Groups

  1. Department of Medicine (281)
  2. Survivorship Research (171)
  3. Solid Tumor Oncology Division (166)
  4. Surgery (130)
  5. Hematologic Malignancies, Division of (113)
  6. Center for Hematologic Malignancies (112)
  7. Genitourinary Oncology Service (91)
  8. Lymphoma (88)
  9. Urology (60)
  10. Radiation Oncology, Department of (58)
  1. "bleomycin"
Formats
  1. Journal Article (520)
  2. Conference Paper (11)
  3. Review (5)
  4. Editorial (3)
  5. Meeting Abstract (3)
  6. Book Section (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (281)
  2. Survivorship Research (171)
  3. Solid Tumor Oncology Division (166)
  4. Surgery (130)
  5. Hematologic Malignancies, Division of (113)
  6. Center for Hematologic Malignancies (112)

More Groups

People
  1. George Bosl (85)
  2. Robert Motzer (59)
  3. Joel Sheinfeld (44)
  4. David Straus (41)
  5. Joachim Yahalom (39)
  6. Dean Bajorin (36)

More People

Years
  1. 2025 (5)
  2. 2024 (14)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (11)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Cancer (38)
  3. Seminars in Oncology (22)
  4. Gynecologic Oncology (19)
  5. Journal of the National Comprehensive Cancer Network (18)
  6. International Journal of Radiation Oncology, Biology, Physics (12)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. American Society of Clinical Oncology (66)
  3. Wiley Blackwell (53)
  4. Lippincott Williams & Wilkins (32)
  5. Springer (28)
  6. Oxford University Press (24)

More Publishers

Results (545)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Carboplatin, etoposide, and bleomycin for patients with poor‐risk germ cell tumors
    Journal Article

    Motzer, R. J.; Cooper, K.; Geller, N. L.; Pfister, D. G.; Lin, S. Y.; Bajorin, D.; Scher, H. I.; Herr, H.; Fair, W.; Morse, M.; more...
    Cancer (1990)

    Fulltext@MSK | Save
  • Neoadjuvant therapy of esophageal cancer
    Conference Paper

    Kelsen, D.
    CMA: Canadian Medical Association (1989)

    Fulltext@MSK | Save
  • Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors
    Journal Article

    Geller, N. L.; Bosl, G. J.; Chan, E. Y. W.
    Cancer (1989)

    Fulltext@MSK | Save
  • Treatment of advanced Hodgkin's disease
    Journal Article

    Straus, D. J.
    Hematology/Oncology Clinics of North America (1989)

    Fulltext@MSK | Save
  • Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease
    Conference Paper

    Yahalom, J.; Gulati, S.; Shank, B.; Clarkson, B.; Fuks, Z.
    Elsevier Inc. (1989)

    Fulltext@MSK | Save
  • Results and prognostic factors following optimal treatment of advanced Hodgkin's disease
    Journal Article

    Straus, D. J.; Gaynor, J.; Myers, J.; Merke, D.; Chapman, D.; Caravelli, J.; Nisce, L. Z.; Lee, B. J.; Clarkson, B. D.
    Recent Results in Cancer Research (1989)

    Fulltext@MSK | Save
  • Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma
    Journal Article

    Markman, M.
    Seminars in Oncology (1989)

    Fulltext@MSK | Save
  • Identification and management of poor risk patients with germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Bosl, G. J.; Geller, N. L.; Bajorin, D.
    Seminars in Oncology (1988)

    Fulltext@MSK | Save
  • Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies
    Journal Article

    Bajorin, D.; Katz, A.; Chan, E.; Geller, N.; Vogelzang, N.; Bosl, G. J.
    Journal of Clinical Oncology (1988)

    Fulltext@MSK | Save
  • Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS)
    Journal Article

    Mandell, L. R.; Ghavimi, F.; Exelby, P.; Fuks, Z.
    International Journal of Radiation Oncology, Biology, Physics (1988)

    Fulltext@MSK | Save